Elmiron Contracts

If your law firm is investigating the causal connection between the drug Elmiron and eye disease, we can help.

Is your law firm currently taking cases on behalf of individuals who have developed eye disorders and have a history of taking Elmiron? Your law firm may be in the prime position to represent people who have suffered eye disease due to Elmiron use. However, you may not have the resources to handle the advertising, screening, qualifying, intake, and retention aspects for the consumers seeking assistance. Atraxia Media is here to help your firm implement a retention campaign and handle the volume of calls that Elmiron cases involve. With our skilled and experienced marketing and media team in place, your law firm could bring in numerous potential clients.

Current signed contract costs: ***subject to change

Elmiron Facts & History Information

Elmiron (pentosan polysulfate sodium) is a prescription medicine used for treating Interstitial Cystitis (IC), also called painful bladder syndrome or bladder pain syndrome. The chronic condition causes painful urinary symptoms and usually affects adult women. Between 3-8 million women and between 1-4 million men in the U.S. suffer from IC.

While there is no cure for IC, various medications, including Elmiron - manufactured by Janssen Pharmaceuticals - may ease some of the symptoms, such as inflammation and bladder discomfort. The FDA approved Elmiron in October 1996. However, several studies show the causal link between Elmiron and progressive retinal damage and central vision impairment diagnosed as macular degeneration, retinal maculopathy, or retinal pigmentary endothelium injury (RPE).

Several dozen eye disorders and vision problems are currently registered in the FDA's FAERS database. In a new case study, the drug's side effects have been linked with the continued deterioration of the eyes for years, even when the drug was stopped.

ELMIRON MDL

All potential Elmiron lawsuits are currently being investigated on the grounds that Janssen Pharmaceuticals was negligent in properly warning patients and doctors of known eye-related injury risks. Accordingly, consumers were not able to make informed decisions for their healthcare and, potentially, avoid injuries.

Atraxia Media has the marketing engine and the infrastructure to qualify and sign potential clients for your Elmiron lawsuits. In turn, you can spend your valuable time focusing on the substantial and legal aspects of claims. If your firm is pursuing cases on behalf of people suffering from vision problems after taking Elmiron, contact us now. Our team is experienced in buying media and providing excellent assistance with selecting the potential clients suitable for your law firm. With Atraxia Media's assistance, your marketing efforts will substantially increase the client base you retain in your Elmiron campaign and your firm's profitability. Conversion of leads into vetted cases can amount to millions of extra dollars in profit for your firm.